gainbot
BriefMoversScreensSectorsEarningsIPOsNewsDividends & splitsScreenerWatchlistLearn
NASDAQ · BYAH

Park Ha Biological Technology Co., Ltd. Ordinary Shares (BYAH)

$2.09−7.52%
Close Nov 5, 2026 · split-adjusted
Nov 5, 2026$2.09▼ 98.35% in range
Nov 5, 2025Low $1.92 · High $126.48Nov 5, 2026
What changed · written from our data
As of Nov 5, 2026

Park Ha Biological Technology Co. closed at $2.09 on Nov 5, down 7.52%, 98.4% below its 52-week closing high. Volume of 12.0K shares was 0.73× its 20-day average (below normal).

Split-adjusted performance: -18.7% over one month, -78.8% over six months, -98.4% over one year.

Short interest was 29.6K shares at the Oct 15 settlement, up 32.9% from the prior report (12.6% of float, 1.0 days to cover).

Market cap$1.7M795.5K shares
Revenue · quarter——
Diluted EPS——
P/E · TTM—
Net margin—
Dividend yieldNone
52-week range1.92 – 128.04−98.4% from high
Volume12.0K0.73× 20-day avg
Volatility · 60d92.1%Annualised
Short % of float12.6%1.0 days to cover
Net cash—
Next earnings—Not scheduled
Split-adjusted performance
1W −9.1%1M −18.7%3M −33.4%6M −78.8%YTD −96.7%1Y −98.4%3Y —5Y —

Earnings reactions

History →

No reported quarters with price history yet.

Rank within industry

Not enough peers to rank

6-month momentum—
Revenue growth—
Net margin—
Value (low P/E)—
Size—

Short interest

Details →
Shares short29.6K+32.9% vs prior
Days to cover1.0Settled Oct 15
% of float12.6%
Short vol. 10d35.2%of daily volume

News about Park Ha Biological Technology Co.

All news →
Bronstein, Gewirtz & Grossman LLC Urges Park Ha Biological Technology Co., Ltd. Investors to Act: Class Action Filed Alleging Investor HarmGlobeNewswire Inc. · Sep 24, 2026▼ NegativePHH, BYAH DEADLINE: ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Park Ha Biological Technology Co., Ltd. Investors to Secure Counsel Before Important September 28 Deadline in Securities Class Action - PHH, BYAHGlobeNewswire Inc. · Sep 24, 2026▼ NegativePHH, BYAH FINAL DEADLINE: ROSEN, LEADING TRIAL ATTORNEYS, Encourages Park Ha Biological Technology Co., Ltd. Investors to Secure Counsel Before Important September 28 Deadline in Securities Class Action - PHH, BYAHGlobeNewswire Inc. · Sep 20, 2026▼ NegativePHH, BYAH DEADLINE NOTICE: ROSEN, A LONGSTANDING LAW FIRM, Encourages Park Ha Biological Technology Co., Ltd. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - PHH, BYAHGlobeNewswire Inc. · Sep 9, 2026▼ NegativePHH, BYAH FINAL DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, Encourages Park Ha Biological Technology Co., Ltd. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - PHH, BYAHGlobeNewswire Inc. · Sep 6, 2026▼ Negative

Quick answers

What does Park Ha Biological Technology Co. do?
Park Ha Biological Technology Co Ltd is engaged in developing its private skincare label, direct skincare products sales, and franchise alliances promotions. Its Park Ha brand focuses on providing solutions for problematic skin.
What is BYAH's market cap?
$1.66M, based on the Nov 5 close of $2.09.
How much of BYAH is sold short?
29.6K shares, 12.6% of float, as of Oct 15, 2026.

About Park Ha Biological Technology Co.

Park Ha Biological Technology Co Ltd is engaged in developing its private skincare label, direct skincare products sales, and franchise alliances promotions. Its Park Ha brand focuses on providing solutions for problematic skin. The company's Operating Subsidiaries provide skincare and cosmetic products under its brand, Park Ha, in China. Its Operating Subsidiaries develop its proprietary beauty products and offer complementary after-sales beauty services in its physical stores.

40 employeesListed Dec 27, 2024parkha.cn

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology